FDA rejects Eli Lilly's proposed Alzheimer's treatment, says more data needed

U.S. drug regulators rejected Eli Lilly & Co.’s proposed new Alzheimer’s disease treatment, saying they need more data from clinical testing, according to the company.

The... U.S. drug regulators rejected Eli Lilly & Co.’s proposed new Alzheimer’s disease treatment, saying they need more data from clinical testing, according to the company. The FDA issued a so-called complete-response letter to Lilly for the company’s application for a speedy FDA approval of the drug, called donanemab, Lilly LLY said Thursday.

But it green-lighted the untested Covid vaccines...

Don't get us started on big pharma concerns when it involves such a needed treatment respecting Alzheimer's people and their families. Safety and clinical trials no doubt are involved as the Covid business gushed with profits for stakeholder/shareholders? Yes, of course. Academic

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Dementia: Brain check-up tool aims to cut risk at any ageYou are never too young to start improving your brain health, an Alzheimer's charity says. Good News Give two simple homeopathic remedies to keep memory intact and also to retrieve failing memory in dementia: Anacardium 200 and Baryta Carb 200, 1+1 drop of these remedies three times a day in a tsf water, takes time but patient will improve. Continue remedies pl do not stop! Maybe 50 years ago when there was 3 channels a public broadcaster was a useful idea. Now it is completely useless and such an antiquated idea DefundtheBBC
Source: bbchealth - 🏆 143. / 63 Read more »

Ex-CEO says Biogen shot itself in foot with Alzheimer's drug priceFormer CEO says Biogen 'shot themselves in the foot' by deciding to charge $56,000 for its controversial Alzheimer's drug
Source: BusinessInsider - 🏆 729. / 51 Read more »